Resource Library

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical and medical device companies remains a consideration for implementation teams.

Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent adoption from sponsor to site.

Download our White Paper: Preparing for Post-Market Clinical Follow-up (PMCF) under EU MDR (European Union Medical Device Regulation) now.

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to Castor

In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process.

Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to its Board of Directors

In this on-demand webinar we dive into the benefits and capabilities of ePRO, and how Castor’s web and mobile ePRO applications empower your hybrid or decentralized trial.